NPCE
Neuropace Inc
12.70$
-4.2%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 29.3% | 29.0% | 25.0% | 23.6% | 24.3% | 25.9% | 27.4% | 26.6% | 27.4% | 26.8% | 28.6% | 31.2% | 28.3% | 27.5% | 25.5% | 24.8% | 26.4% | 26.6% | 26.8% | 24.6% | 23.0% | 22.9% | 22.6% | 22.6% | 18.2% | 17.2% | 20.4% | |
| 70.7% | 71.0% | 75.0% | 76.4% | 75.7% | 74.1% | 72.6% | 73.4% | 72.6% | 73.2% | 71.4% | 68.8% | 71.7% | 72.5% | 74.5% | 75.2% | 73.6% | 73.4% | 73.2% | 75.4% | 77.0% | 77.1% | 77.4% | 77.4% | 81.8% | 82.8% | 79.6% | |
| 48.5% | 42.6% | 28.9% | 36.4% | 36.6% | 35.1% | 41.9% | 48.6% | 49.0% | 55.6% | 50.3% | 39.8% | 36.4% | 32.4% | 29.2% | 29.9% | 31.9% | 31.5% | 27.3% | 28.2% | 33.0% | 29.1% | 24.0% | 26.4% | 32.6% | 30.2% | 28.0% | |
| 77.0% | 73.5% | 55.2% | 67.7% | 73.7% | 75.4% | 91.1% | 106.8% | 109.4% | 125.2% | 112.5% | 106.1% | 92.8% | 87.7% | 81.5% | 73.4% | 83.3% | 23.6% | 66.0% | 64.2% | 18.0% | 25.8% | 16.8% | 16.5% | 22.0% | 22.0% | 19.1% | |
| 125.5% | 116.1% | 84.1% | 104.2% | 110.3% | 110.6% | 133.0% | 155.4% | 158.4% | 180.8% | 162.8% | 145.9% | 129.2% | 120.1% | 110.7% | 103.2% | 115.3% | 105.8% | 93.4% | 92.4% | 99.8% | 106.1% | 86.9% | 84.0% | 107.0% | 105.4% | 94.9% | |
| -54.7% | -45.1% | -9.1% | -27.7% | -34.5% | -36.5% | -60.4% | -82.0% | -85.8% | -107.6% | -91.4% | -77.1% | -57.5% | -47.6% | -36.2% | -28.0% | -41.6% | -32.4% | -20.1% | -17.0% | -22.9% | -29.0% | -9.5% | -6.6% | -25.2% | -22.5% | -15.3% | |
| 30.1% | 49.9% | 21.9% | 17.1% | 16.5% | 14.8% | 17.7% | 16.9% | 16.1% | 18.2% | 17.1% | 15.2% | 13.6% | 12.9% | 13.3% | 12.4% | 12.5% | 11.2% | 10.4% | 10.2% | 9.6% | 8.8% | 6.0% | 6.0% | 6.9% | 6.7% | 6.4% | |
| -67.6% | -115.1% | -32.3% | -43.0% | -78.5% | -67.3% | -78.2% | -97.2% | -100.8% | -124.4% | -105.6% | -87.2% | -71.7% | -55.3% | -44.2% | -34.4% | -49.2% | -39.0% | -25.9% | -24.5% | -29.3% | -36.8% | -12.8% | -10.3% | -30.3% | -27.2% | -19.3% | |
| 47.2% | 29.8% | 20.5% | 19.4% | -11.0% | -1.1% | 17.5% | -1.7% | 14.9% | 16.8% | 14.2% | 10.1% | 27.8% | 13.6% | 14.0% | -47.6% | 2.1% | – | – | -1.8% | – | – | – | -32.5% | – | – | – | |
| -67.6% | -115.1% | -32.3% | -43.0% | -78.5% | -67.3% | -78.2% | -97.2% | -100.8% | -124.4% | -105.6% | -87.2% | -71.7% | -55.3% | -44.2% | -34.4% | -49.2% | -39.0% | -25.9% | -24.5% | -29.3% | -36.8% | -12.8% | -10.3% | -30.3% | -27.2% | -19.3% | |
| -36.7% | -64.1% | -9.8% | -24.8% | -61.4% | -51.9% | -59.8% | -79.6% | -78.1% | -99.0% | -81.9% | -66.1% | -55.4% | -40.0% | -28.4% | -19.7% | -34.5% | -25.5% | -13.4% | -12.1% | -17.6% | -26.0% | -9.0% | -2.3% | -21.1% | -20.0% | -12.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.